Contac 12 hour and Ards (acute respiratory distress syndrome) - a phase IV clinical study of FDA data
Summary:
Ards (acute respiratory distress syndrome) is reported only by a few people who take Contac 12 Hour.
The phase IV clinical study analyzes which people take Contac 12 hour and have Ards (acute respiratory distress syndrome). It is created by eHealthMe based on reports of 1,131 people who have side effects while taking Contac 12 hour from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,131 people reported to have side effects when taking Contac 12 hour.
Among them, 3 people (0.27%) have Ards (acute respiratory distress syndrome).
What is Contac 12 hour?
Contac 12 hour has active ingredients of chlorpheniramine maleate; phenylpropanolamine hydrochloride. eHealthMe is studying from 1,137 Contac 12 hour users for its effectiveness, alternative drugs and more.
What is Ards (acute respiratory distress syndrome)?
Ards (acute respiratory distress syndrome) (sudden failure of the respiratory (breathing) system) is found to be associated with 2,416 drugs and 2,215 conditions by eHealthMe.
Number of Contac 12 hour and Ards (acute respiratory distress syndrome) reports submitted per year:
/could-contac-12-hour-cause-ards-(acute-respiratory-distress-syndrome).png)
Time on Contac 12 hour when people have Ards (acute respiratory distress syndrome) *:
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Ards (acute respiratory distress syndrome) when taking Contac 12 hour *:
- female: 66.67 %
- male: 33.33 %
Age of people who have Ards (acute respiratory distress syndrome) when taking Contac 12 hour *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 33.33 %
- 20-29: 0.0 %
- 30-39: 33.33 %
- 40-49: 33.33 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common drugs people take besides Contac 12 hour *:
- Ziac: 1 person, 33.33%
- Lotrel: 1 person, 33.33%
- Indapamide: 1 person, 33.33%
- Ibuprofen: 1 person, 33.33%
- Dimetapp: 1 person, 33.33%
Common side effects people have besides Ards (acute respiratory distress syndrome) *:
- Blood Glucose Increased: 2 people, 66.67%
- White Blood Cell Count Increased: 1 person, 33.33%
- Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 33.33%
- Hepatitis B: 1 person, 33.33%
- Heart Rate Decreased: 1 person, 33.33%
- Haemorrhagic Stroke (stroke caused by the rupture of a blood vessel in the brain): 1 person, 33.33%
- Haemoglobin Decreased: 1 person, 33.33%
- Haematocrit Decreased: 1 person, 33.33%
- Essential Hypertension (primary hypertension): 1 person, 33.33%
- Emotional Distress: 1 person, 33.33%
* Approximation only. Some reports may have incomplete information.
Do you take Contac 12 hour and have Ards (acute respiratory distress syndrome)?
Check whether Ards (acute respiratory distress syndrome) is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Ards (acute respiratory distress syndrome) and when was it recovered:
Expand to all the drugs that have ingredients of chlorpheniramine maleate; phenylpropanolamine hydrochloride:
Alternative drugs to, pros and cons of Contac 12 hour:
- Contac 12 hour (1,137 reports)
Common Contac 12 hour side effects:
- High blood pressure: 371 reports
- Pain: 362 reports
- Heart attack: 270 reports
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 268 reports
- Stress and anxiety: 244 reports
- Memory loss: 123 reports
Browse all side effects of Contac 12 hour:
a b c d e f g h i j k l m n o p q r s t u v w x y zArds (acute respiratory distress syndrome) treatments and more:
- Ards (acute respiratory distress syndrome) (23,537 reports)
COVID vaccines that are related to Ards (acute respiratory distress syndrome):
- Ards (acute respiratory distress syndrome) in Moderna COVID Vaccine
- Ards (acute respiratory distress syndrome) in Pfizer BioNTech Covid Vaccine
- Ards (acute respiratory distress syndrome) in Johnson and Johnson Covid Vaccine
Common drugs associated with Ards (acute respiratory distress syndrome):
- Prednisone: 1,750 reports
- Methotrexate: 1,504 reports
- Prednisolone: 1,043 reports
- Cyclophosphamide: 1,029 reports
- Furosemide: 778 reports
- Aspirin: 671 reports
- Tacrolimus: 654 reports
- Mycophenolate mofetil: 653 reports
- Omeprazole: 651 reports
- Cytarabine: 641 reports
All the drugs that are associated with Ards (acute respiratory distress syndrome):
- Ards (acute respiratory distress syndrome) (2,416 drugs)
Common conditions associated with Ards (acute respiratory distress syndrome):
- Rheumatoid arthritis: 955 reports
- High blood pressure: 751 reports
- Pain: 464 reports
- Multiple myeloma: 458 reports
- Atrial fibrillation/flutter: 420 reports
- Preventive health care: 382 reports
- Depression: 330 reports
All the conditions that are associated with Ards (acute respiratory distress syndrome):
- Ards (acute respiratory distress syndrome) (2,215 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on chlorpheniramine maleate; phenylpropanolamine hydrochloride (the active ingredients of Contac 12 hour) and Contac 12 hour (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Dandelion and Irritable Bowel Syndrome - now
- Rituxan and Weight Loss - 3 seconds ago
- Metaproterenol Sulfate vs. Felodipine - 6 seconds ago
- Gymnema Sylvestre vs. Lyrica - 7 seconds ago
- Ocaliva and Gastroesophageal Reflux Disease - 7 seconds ago
- Desvenlafaxine vs. Seroquel Xr - 8 seconds ago
- Oxycodone and Muscle Atrophy - 10 seconds ago
- Levoxyl and Enlarged Prostate - 11 seconds ago
- Aldomet vs. Spironolactone - 12 seconds ago
- Lexapro vs. Colestid - 13 seconds ago